Clinical characteristics and risk factors of macrovascular diseases in patients with different subtypes of type 1 diabetes mellitus

Clinical characteristics and risk factors of macrovascular diseases in patients with different subtypes of type 1 diabetes mellitus

Objective To investigate the clinical characteristics of different subtypes of type 1 diabetes mellitus(T1DM) patients and to analyze the risk of macrovascular diseases in different subtypes of T1DM patients. Methods The clinical data among 79 T1DM patients who treated in the Endocrinology Departm...

Full description

Bibliographic Details
Main Author:	WANG Liting, XU Lingling, LI Wei, PING Fan, ZHANG Huabing, MA Yahong, LI Yuxiu
Format:	Article
Language:	zho
Published:	Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2023-08-01
Series:	Jichu yixue yu linchuang
Subjects:	type 1 diabetes mellitus\|macrovascular diseases\|idiopathic\|autoimmunity\|islet autoantibody
Online Access:	http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2023-43-8-1284.pdf

Similar Items

Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications
by: Wei Yang, et al.
Published: (2017-10-01)

Symposium 13: Impact of prediabetes on macrovascular disease
by: Carolina Gómez Martin
Published: (2022-09-01)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
by: Aastha Chawla, et al.
Published: (2016-01-01)

Subclinical Hypothyroidism as a Contributor to Macrovascular Complications in Patients with Type 2 Diabetes Mellitus
by: Mariya Marushchak, et al.
Published: (2021-01-01)

Prevalence of Autoantibodies Against Pancreatic Beta Cells in Children with Type 1 Diabetes Mellitus
by: Zahra Panahivand, et al.
Published: (2023-12-01)

Risk management of micro- and macrovascular complications of diabetes mellitus: the importance of glycemic self-control
by: Olga A. Polyakova, et al.
Published: (2021-08-01)

Advances in risk predictive performance of pre-symptomatic type 1 diabetes via the multiplex Antibody-Detection-by-Agglutination-PCR assay
by: Devangkumar Tandel, et al.
Published: (2024-02-01)

The importance of self-control, and education of patients with diabetes mellitus type 2 in the prevention of micro and macrovascular complications
by: Sandra Živanović, et al.
Published: (2013-01-01)

Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
by: Hu Y, et al.
Published: (2021-06-01)

Markers for hepatic autoimmune disorders in patients with type 1 diabetes mellitus
by: Olga Sergeevna Derevyanko, et al.
Published: (2014-03-01)

Advances in secondary prevention mechanisms of macrovascular complications in type 2 diabetes mellitus patients: a comprehensive review
by: Huifang Guan, et al.
Published: (2024-03-01)

The Impact of Dietary Factors during Pregnancy on the Development of Islet Autoimmunity and Type 1 Diabetes: A Systematic Literature Review
by: Valdemar Brimnes Ingemann Johansen, et al.
Published: (2023-10-01)

Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting
by: KM Erny-Albrecht, et al.
Published: (2009-03-01)

Prevalence of hypertension in type-2 diabetes mellitus
by: K Venugopal, et al.
Published: (2014-01-01)

Evaluating the Prognostic Value of Islet Autoantibody Monitoring in Islet Transplant Recipients with Long-Standing Type 1 Diabetes Mellitus
by: Roi Anteby, et al.
Published: (2021-06-01)

Graft failure after allogeneic islet transplantation in a patient with type 1 diabetes and a high anti‐glutamic acid decarboxylase antibody titer
by: Noriko Kodani, et al.
Published: (2023-05-01)

Variant rs2237892 of KCNQ1 Is Potentially Associated with Hypertension and Macrovascular Complications in Type 2 Diabetes Mellitus in A Chinese Han Population
by: Wanlin Zhang, et al.
Published: (2015-12-01)

Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin
by: Resham R Poudel
Published: (2012-01-01)

Islet autoantibody positivity in overweight and obese adults with type 2 diabetes
by: Scott J. Pilla, et al.
Published: (2018-11-01)

Autoantibodies in Type 1 Diabetes: A Retrospective Study of Children Diagnosed Under Ten Years of Age
by: Cristiana Maximiano, et al.
Published: (2023-09-01)

Predominant Complications of Type 2 Diabetes in Kumasi: A 4-Year Retrospective Cross-Sectional Study at a Teaching Hospital in Ghana
by: Max Efui Annani-Akollor, et al.
Published: (2019-05-01)

The Prediction of Macrovascular Complications in Individuals with Type 2 diabetes mellitus with Different Risk Factors in ThiQar
by: Shahad Turkey Mana, et al.
Published: (2023-04-01)

CXADR polymorphism rs6517774 modifies islet autoimmunity characteristics and exhibits sex disparity
by: Lucas Nygård, et al.
Published: (2023-11-01)

Impact of Nutraceuticals on Type 1 and Type 2 Diabetes Mellitus-Induced Micro- and Macrovasculopathies
by: Philanathi Mabena, et al.
Published: (2023-12-01)

Estimation of Insulin and Glutamic Acid Decarboxylase Autoantibodies In Patients With Type 1 Diabetes Mellitus
by: Abbas J Mohammed
Published: (2019-06-01)

Estimation of Insulin and Glutamic Acid Decarboxylase Autoantibodies In Patients With Type 1 Diabetes Mellitus
by: Abbas J Mohammed
Published: (2019-06-01)

Significance of Hematological Parameters in Patients with Type-2 Diabetes Mellitus and Its Relationship with Disease Complications
by: Faraz Ali Rana, et al.
Published: (2023-02-01)

Type 1 diabetes pathogenesis - Prevention???
by: C S Muralidhara Krishna, et al.
Published: (2015-01-01)

Correlations between the severity of cardiovascular autonomic neuropathy and other complications in type 2 diabetes mellitus
by: Anca Motataianu, et al.
Published: (2016-03-01)

Clinical features of childhood diabetes mellitus focusing on latent autoimmune diabetes
by: Seung Ho Lee, et al.
Published: (2016-12-01)

The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)
by: Gemma Llauradó, et al.
Published: (2022-10-01)

The risk of micro and macrovascular disease in Egyptian patients with diabetes and peripheral arterial disease
by: Maha Assem, et al.
Published: (2021-03-01)

Chronic kidney disease in patients with long-term type 1 diabetes mellitus
by: M. I. Yevloyeva, et al.
Published: (2023-12-01)

Increased levels of anti-BSA antibodies in children with Down syndrome
by: Sian L. Grace, et al.
Published: (2023-02-01)

Ketosis-prone type 2 diabetes mellitus (review of the literature)
by: Natalya Alexandrovna Molitvoslovova,, et al.
Published: (2009-09-01)

Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus
by: Gurgel Penaforte-Saboia J, et al.
Published: (2021-02-01)

Adenosine Deaminase- Relation with Diabetes and its Complication
by: Saqib Hyder Shah, et al.
Published: (2020-10-01)

Endogenous Levels of Gamma Amino-Butyric Acid Are Correlated to Glutamic-Acid Decarboxylase Antibody Levels in Type 1 Diabetes
by: Henrik Hill, et al.
Published: (2021-12-01)

Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study
by: Berglind Jonsdottir, et al.
Published: (2018-07-01)

Diabetes mellitus and periodontal disease
by: Teodor Salmen, et al.
Published: (2021-12-01)